MPI Research

Mattawan, United States Founded: 1995 • Age: 31 yrs Acquired By Charles River Laboratories
CRO offering preclinical and clinical development services

About MPI Research

MPI Research is a company based in Mattawan (United States) founded in 1995 was acquired by Charles River Laboratories in February 2018. MPI Research has completed 1 acquisition, including Jasper Clinic. MPI Research offers products and services including Ototoxicity Testing, Abuse and Dependence Liability Testing, Surgical Services, Ocular Toxicology, and Infectious Disease Models. MPI Research operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.

Key Metrics

Products & Services of MPI Research

MPI Research offers a comprehensive portfolio of products and services, including Ototoxicity Testing, Abuse and Dependence Liability Testing, Surgical Services, Ocular Toxicology, and Infectious Disease Models.

Ototoxicity Testing
Toxicology Services

Assesses potential hearing damage from pharmaceutical compounds

Abuse and Dependence Liability Testing
Safety Assessment

Evaluates addiction risks of drugs and substances

Surgical Services
Medical Device Development

Supports development and testing of medical devices

Ocular Toxicology
Toxicology Services

Tests eye-related effects of drugs and chemicals

Infectious Disease Models
Disease Research

Studies vaccine safety and efficacy for infections

Molecular Imaging
Analytical Services

Uses imaging techniques for drug development research

Cell and Gene Therapy
Therapeutic Services

Provides testing for cell and gene-based treatments

Radiochemistry
Analytical Services

Conducts chemical analysis for pharmaceutical applications

Funding Insights of MPI Research

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of MPI Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2008–Private Equity Round––
Valuation history

2 investors in total: 2 institutional.

Investors in MPI Research

MPI Research has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Charles River Laboratories and TA Associates.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by private equity firm TA.
–ta.comBoston, United States
Provider of drug discovery and preclinical development services
1947criver.comWilmington, United States
Premium access

Investor details for MPI Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MPI Research

MPI Research has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Jasper Clinic.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of phase 1-2a clinical pharmacology services for medical and diagnostic devices
jasperclinic.comKalamazoo, United States0Oct 2014β€’β€’β€’β€’
Premium access

Complete acquisition details for MPI Research

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MPI Research

4 dated milestones of MPI Research across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded MPI Research is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Jasper Clinic.
  4. Exit Acquired by Charles River Laboratories.

Competitors of MPI Research

MPI Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
criver.com1947Wilmington, United States–21,400
Provider of drug discovery and preclinical development services
labcorp.com1969Burlington, United States–9,321
Provider of laboratory tests for physicians
cytel.com1987Cambridge, United States$2M509
Data analysis and statistical solutions are provided for life sciences.
precisionmedicinegrp.com2012Bethesda, United States$257.21M2,151
Provider of clinical research, development, and commercialization services for life sciences
veedacr.com2004Ahmedabad, India––
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
precisionformedicine.com2013Bethesda, United States$150M–
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
covance.com1996Princeton, United States––
CRO offering comprehensive drug development solutions from drug discovery to life cycle management
qps.com1995Newark, United States––
Contract research organisation offering drug discovery, preclinical and clinical development services
frontagelab.com2001Exton, United States$10.24M–
Early drug development services are provided for pharma firms.
canopybiosciences.com2016St. Louis, United States$4.48M–
Cell line engineering services are offered via CRISPR-Cas9 technology.
Premium access

Detailed competitors of MPI Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MPI Research

Websites that share an audience with MPI Research (mpiresearch.com).

Similar websites

Websites whose visitors overlap most with MPI Research. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
productsafetylabs.com
100%
–#11,646,809View details
mbresearch.com
mbresearch.com
95%
–#13,344,910–
lumigen.com
82%
––View details
vai.org
82%
36.3K#787,837View details
lampire.com
79%
–#2,833,014View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 19 similar websites and full traffic analytics for MPI Research

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Mpi Research

Premium access

Complete news archive for MPI Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to MPI Research

10 companies that operate in the same segment as MPI Research (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MPI Research

MPI Research was founded in 1995 and raised its 1st funding round 13 years after it was founded.

MPI Research is headquartered in Mattawan, United States. It is registered at Mattawan, Michigan, United States.

Founded in 1995 and based in Mattawan, United States, MPI Research operates as a contract research organization in the biotechnology and pharmaceutical sectors. Preclinical and clinical development services are delivered, including drug safety assessments, discovery support, analytical testing, medical device evaluations, translational imaging, and clinical studies. Specialty services address therapeutic areas such as metabolic disorders, cardiovascular conditions, orthopaedics, renal issues, neurosciences, inflammation, infectious diseases, oncology, ophthalmology, and stem cell applications.

MPI Research's top competitors include LabCorp, Charles River Laboratories and Cytel.

MPI Research offers Ototoxicity Testing, Abuse and Dependence Liability Testing, Surgical Services, Ocular Toxicology, and 4 more products and services.

MPI Research has made 1 acquisition, including Jasper Clinic.

MPI Research has 2 investors. Key investors include Charles River Laboratories, and TA Associates.

Yes. MPI Research was acquired by Charles River Laboratories in February 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available